Cancer Res. 1996 Aug 15;56(16):3663-5.

High prevalence of the 999del5 mutation in icelandic breast and ovarian cancer patients.

Johannesdottir G, Gudmundsson J, Bergthorsson JT, Arason A, Agnarsson BA, Eiriksdottir G, Johannsson OT, Borg A, Ingvarsson S, Easton DF, Egilsson V, Barkardottir RB.

Source

Department of Pathology, University Hospital of Iceland, Reykjavik, Iceland.

Abstract

Studies on Icelandic breast cancer families have shown that most of them segregate a 999del5 BRCA2 mutation. Here, we report the frequency of the 999del5 BRCA2 mutation in an Icelandic control population and four different groups of cancer patients diagnosed with (a) breast cancer; (b) ovarian cancer; (c) prostate cancer (patients younger than 65 years); and (d) other cancer types. The proportions of individuals carrying the mutation were 0.4% in the control population and in the patient groups 8.5%, 7.9%, 2.7%, and 1.0%, respectively. Our results indicate that BRCA2 confers a very high risk of breast cancer and is responsible for a substantial fraction of breast and ovarian cancer in Iceland, but only a small proportion of other cancers.

PMID:: 8706004; [PubMed - indexed for MEDLINE]

Free full text

LinkOut - more resources

Full Text Sources

HighWire Press

Medical

Libraries

LinkOut Holdings

Supplemental Content

Related citations

Study of a single BRCA2 mutation with high carrier frequency in a small population. [Am J Hum Genet. 1997]
Study of a single BRCA2 mutation with high carrier frequency in a small population.
Thorlacius S, Sigurdsson S, Bjarnadottir H, Olafsdottir G, Jonasson JG, Tryggvadottir L, Tulinius H, Eyfjörd JE. Am J Hum Genet. 1997 May; 60(5):1079-84.
A low proportion of BRCA2 mutations in Finnish breast cancer families. [Am J Hum Genet. 1997]
A low proportion of BRCA2 mutations in Finnish breast cancer families.
Vehmanen P, Friedman LS, Eerola H, Sarantaus L, Pyrhönen S, Ponder BA, Muhonen T, Nevanlinna H. Am J Hum Genet. 1997 May; 60(5):1050-8.
A population study of mutations and LOH at breast cancer gene loci in tumours from sister pairs: two recurrent mutations seem to account for all BRCA1/BRCA2 linked breast cancer in Iceland. [J Med Genet. 1998]
A population study of mutations and LOH at breast cancer gene loci in tumours from sister pairs: two recurrent mutations seem to account for all BRCA1/BRCA2 linked breast cancer in Iceland.
Arason A, Jonasdottir A, Barkardottir RB, Bergthorsson JT, Teare MD, Easton DF, Egilsson V. J Med Genet. 1998 Jun; 35(6):446-9.
Review Inherited susceptibility to breast and ovarian cancer. [Curr Opin Obstet Gynecol. 1998]
Review Inherited susceptibility to breast and ovarian cancer.
Diamond TM, Sutphen R, Tabano M, Fiorica J. Curr Opin Obstet Gynecol. 1998 Feb; 10(1):3-8.
Review Histology of prophylactically removed ovaries from BRCA1 and BRCA2 mutation carriers compared with noncarriers in hereditary breast ovarian cancer syndrome kindreds. [Gynecol Oncol. 2000]
Review Histology of prophylactically removed ovaries from BRCA1 and BRCA2 mutation carriers compared with noncarriers in hereditary breast ovarian cancer syndrome kindreds.
Casey MJ, Bewtra C, Hoehne LL, Tatpati AD, Lynch HT, Watson P. Gynecol Oncol. 2000 Sep; 78(3 Pt 1):278-87.

See reviews... See all...

Cited by 35 PubMed Central articles

Genome-wide search for breast cancer linkage in large Icelandic non-BRCA1/2 families. [Breast Cancer Res. 2010]
Genome-wide search for breast cancer linkage in large Icelandic non-BRCA1/2 families.
Arason A, Gunnarsson H, Johannesdottir G, Jonasson K, Bendahl PO, Gillanders EM, Agnarsson BA, Jönsson G, Pylkäs K, Mustonen A, et al. Breast Cancer Res. 2010; 12(4):R50. Epub 2010 Jul 16.
Family history of cancer and risk of pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan). [Int J Cancer. 2010]
Family history of cancer and risk of pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan).
Jacobs EJ, Chanock SJ, Fuchs CS, Lacroix A, McWilliams RR, Steplowski E, Stolzenberg-Solomon RZ, Arslan AA, Bueno-de-Mesquita HB, Gross M, et al. Int J Cancer. 2010 Sep 1; 127(6):1421-8.
No evidence of BRCA2 mutations in chromosome 13q-linked Utah high-risk prostate cancer pedigrees. [BMC Res Notes. 2009]
No evidence of BRCA2 mutations in chromosome 13q-linked Utah high-risk prostate cancer pedigrees.
Allen-Brady K, Farnham JM, Camp NJ, Karlins E, Ostrander EA, Cannon-Albright LA. BMC Res Notes. 2009 May 28; 2:94. Epub 2009 May 28.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
OMIM (calculated)
Online Mendelian Inheritance in Man (OMIM) records that include the current articles as references in the light bulb links within or in the citations at the end of the OMIM record. The references available through the light bulb link are collected using the PubMed related articles algorithm to identify records with similar terminology to the OMIM record.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

High prevalence of the 999del5 mutation in icelandic breast and ovarian cancer p...
High prevalence of the 999del5 mutation in icelandic breast and ovarian cancer patients.
Cancer Res. 1996 Aug 15 ;56(16):3663-5.

PubMed
Melanin formation in the inner ear is catalyzed by a new tyrosine hydroxylase ki...
Melanin formation in the inner ear is catalyzed by a new tyrosine hydroxylase kinetically and structurally different from tyrosinase.
Biochim Biophys Acta. 1997 Jul 19 ;1336(1):59-72.

PubMed
A population study of mutations and LOH at breast cancer gene loci in tumours fr...
A population study of mutations and LOH at breast cancer gene loci in tumours from sister pairs: two recurrent mutations seem to account for all BRCA1/BRCA2 linked breast cancer in Iceland.
J Med Genet. 1998 Jun ;35(6):446-9.

PubMed
Demonstration of the adherence of Streptococcus pyogenes to the surface of human...
Demonstration of the adherence of Streptococcus pyogenes to the surface of human tonsillar tissue.
Am J Otolaryngol. 1980 Aug ;1(4):269-74.

PubMed
Identification of a novel splice-site mutation of the BRCA1 gene in two breast c...
Identification of a novel splice-site mutation of the BRCA1 gene in two breast cancer families: screening reveals low frequency in Icelandic breast cancer patients.
Hum Mutat. 1998 ;Suppl 1:S195-7.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to:

High prevalence of the 999del5 mutation in icelandic breast and ovarian cancer patients.

Source

Abstract

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Libraries

Supplemental Content

Related citations

Cited by 35 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information